Alzheimer’s Disease
Latest News in Alzheimer’s Disease
April 1, 2025
This Underrated Drink Could Help Slow the Progression of Alzheimer’s, New Study Says – EatingWell
April 1, 2025
Although valiltramiprosate failed to distinguish itself from placebo on the primary end point, the drug performed significantly better among mild MCI participants vs those with mild Alzheimer disease.
April 1, 2025
Xanamem Shows Potential in Slowing Alzheimer Progression in Patients With Elevated Plasma pTau181
A phase 2a biomarker trial of xanamem presented at AD/PD 2025 suggests the drug may help slow clinical decline in patients with Alzheimer who have elevated levels of plasma pTau181.
831 Active Alzheimer’s Disease Clinical Trials
Source: clinicaltrials.gov
LOCATE
CLINICAL TRIALS
BROWSE
FDA-approved DRUGS
WHAT IS
CONGRESS DOING?
© Copyright 2020-2025 Seeking Cure, Inc. All Rights Reserved. Third Party materials included herein protected under copyright law.
Seeking Cure is a registered trademark of Seeking Cure, Inc.
Use of this website and any information contained herein is governed by Seeking Cure’s Terms of Service and Privacy Policy. This website is provided for general information purposes only. This website does not provide medical advice. Always consult an appropriately licensed medical provider for diagnosis and treatment. Seeking Cure does not warrant the accuracy, completeness, or timeliness of the information. Content and other features are subject to change or termination without notice at the discretion of Seeking Cure.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.